Document is current

Article History

Accepted: 18 October 2023

First Online: 9 November 2023

Declarations

:

: Open Access funding enabled and organized by CAUL and its Member Institutions. This research was partially funded by grants to ACH and LAD from the Rebecca Cooper Foundation and Australia’s National Health and Medical Research Council, as well as a Research Training Program Stipend from Swinburne University to BM.

: Thomas R. Arkell reports receiving speaker fees from Althea, NUBU Pharmaceuticals, and the International College of Cannabinoid Medicine, as well as grants from the Barbara Dicker Foundation outside the submitted work. Brooke Manning reports no conflicts of interest. Luke A. Downey reports receiving grants from the National Health and Medical Research Council, grants from Cannvalate, and grants from the Barbara Dicker Foundation outside the submitted work. Amie C. Haley reports receiving grants from Cannvalate, the Rebecca L. Cooper Foundation for the Al and Val Rosenstrauss Fellowship (F2021894), the Barbara Dicker Foundation, and the Road Safety Innovation Fund outside the submitted work.

: Requests for access to study data can be submitted to the corresponding author.

: All procedures were approved by the Swinburne University Human Research Ethics Committee and conducted in accordance with the Declaration of Helsinki.

: All participants provided written, informed consent prior to participating.

: Not applicable.

: The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.

: Not applicable.

: Conceptualization: TRA, LAD, ACH. Data acquisition: TRA, ACH. Statistical analysis: TRA, BM. Drafting of the manuscript: TRA. Reviewing and editing: BM, LAD, ACH. All authors reviewed the manuscript, revised it critically for important intellectual content, have read and approved the final submitted manuscript, and agree to be accountable for this work.